LeadIQ logo
Learn more at LeadIQ.com

Insights

Unique Treatment Approval Geron Corporation is the only company with an FDA-approved oligonucleotide telomerase inhibitor for the treatment of lower-risk myelodysplastic syndromes. This unique offering positions the company well to attract customers looking for innovative treatment options in the biotechnology sector.

Commercial Drug Launch Geron Corporation successfully launched its drug Rytelo in the U.S. with promising initial results. This recent commercialization presents a sales opportunity to engage healthcare institutions and providers seeking advanced therapies for complex blood cancers.

Appointment of Key Executives With the appointment of experienced executives like Jim Ziegler as Chief Commercial Officer and Scott Samuels as Chief Financial Officer, Geron Corporation demonstrates a commitment to strategic leadership. This signals stability and growth potential, which can be leveraged to foster lasting business partnerships and sales engagements.

Strategic Investor Engagement The recent investment of $9.63 million by Boxer Capital, LLC into Geron Corporation showcases external confidence in the company's vision and potential. This financial backing can be utilized to intensify sales efforts, expand market reach, and acquire new customers.

Focus on Innovative Therapies Geron Corporation's focus on developing innovative therapies for complex diseases reflects a commitment to addressing unmet medical needs. This emphasis on cutting-edge solutions presents a sales opportunity to engage with healthcare professionals and organizations looking for groundbreaking treatment options.

Similar companies to Geron Corporation

Geron Corporation Tech Stack

Geron Corporation uses 8 technology products and services including Snowplow, Oracle, Microsoft Dynamics, and more. Explore Geron Corporation's tech stack below.

  • Snowplow
    Analytics
  • Oracle
    Enterprise
  • Microsoft Dynamics
    Enterprise Resource Planning
  • Google Font API
    Font Scripts
  • Underscore.js
    Javascript Libraries
  • Windows Server
    Operating Systems
  • Smartsheet
    Project Management
  • Microsoft ASP.NET
    Web Frameworks

Geron Corporation's Email Address Formats

Geron Corporation uses at least 1 format(s):
Geron Corporation Email FormatsExamplePercentage
FLast@geron.comJDoe@geron.com
90%
Last@geron.comDoe@geron.com
8%
FL@geron.comJD@geron.com
1%
F.Last@geron.comJ.Doe@geron.com
1%

Frequently Asked Questions

Where is Geron Corporation's headquarters located?

Minus sign iconPlus sign icon
Geron Corporation's main headquarters is located at 919 E Hillsdale Blvd Foster City, California 94404 US. The company has employees across 6 continents, including North AmericaEuropeAsia.

What is Geron Corporation's phone number?

Minus sign iconPlus sign icon
You can contact Geron Corporation's main corporate office by phone at . For more prospecting data, LeadIQ has access to up-to-date and accurate contact information within our platform. Find, capture, and sync contact data to your CRM and sales tools in one click.

What is Geron Corporation's stock symbol?

Minus sign iconPlus sign icon
Geron Corporation is a publicly traded company; the company's stock symbol is GERN.

What is Geron Corporation's official website and social media links?

Minus sign iconPlus sign icon
Geron Corporation's official website is geron.com and has social profiles on LinkedIn.

How much revenue does Geron Corporation generate?

Minus sign iconPlus sign icon
As of October 2024, Geron Corporation's annual revenue reached $75M.

What is Geron Corporation's SIC code NAICS code?

Minus sign iconPlus sign icon
Geron Corporation's SIC code is 2834 - Pharmaceutical Preparations NAICS code is 541714 - Research and Development in Biotechnology (except Nanobiotechnology).

How many employees does Geron Corporation have currently?

Minus sign iconPlus sign icon
As of October 2024, Geron Corporation has approximately 361 employees across 6 continents, including North AmericaEuropeAsia. Key team members include Chief People Officer: S. O.Chief Financial Officer: M. R.Chief Medical Officer: F. F.. Explore Geron Corporation's employee directory with LeadIQ.

What industry does Geron Corporation belong to?

Minus sign iconPlus sign icon
Geron Corporation operates in the Biotechnology Research industry.

What technology does Geron Corporation use?

Minus sign iconPlus sign icon
Geron Corporation's tech stack includes SnowplowOracleMicrosoft DynamicsGoogle Font APIUnderscore.jsWindows ServerSmartsheetMicrosoft ASP.NET.

What is Geron Corporation's email format?

Minus sign iconPlus sign icon
Geron Corporation's email format typically follows the pattern of . Find more Geron Corporation email formats with LeadIQ.

How much funding has Geron Corporation raised to date?

Minus sign iconPlus sign icon
As of October 2024, Geron Corporation has raised $150M in funding. The last funding round occurred on Mar 19, 2024 for $150M.

When was Geron Corporation founded?

Minus sign iconPlus sign icon
Geron Corporation was founded in 1992.
Geron Corporation

Geron Corporation

Biotechnology ResearchCalifornia, United States201-500 Employees

Geron is a biopharmaceutical company that is charting a new course with the goal to deliver innovative treatment options for people living with blood cancer. Our tireless pursuit to improve outcomes for these patients resulted in the U.S. approval of the first ever telomerase inhibitor for the treatment of certain adult patients with lower-risk myelodysplastic syndromes (LR-MDS) with transfusion-dependent anemia. 

As the sole company with an oligonucleotide telomerase inhibitor approved by the FDA, we feel a deep urgency to bring the potential power of telomerase inhibition to patients in need. We are conducting research in other blood cancers with high unmet need beyond LR-MDS, with ongoing clinical trials across other hematologic malignancies, including a pivotal Phase 3 clinical trial in JAK-inhibitor relapsed/refractory myelofibrosis (R/R MF). 

We are proud of the impact this Nobel-winning science is having in the fight against blood cancers. At Geron, we are united by a shared purpose: Every individual in every role can meaningfully contribute to our mission to change lives by changing the course of blood cancer. With a culture rooted in courage and determination, we will continue to innovate and pursue new possibilities for patients. 

To learn more, visit www.geron.com.

Geron’s Community Guidelines: https://www.geron.com/CommunityGuidelines/

Section iconCompany Overview

Headquarters
919 E Hillsdale Blvd Foster City, California 94404 US
Phone number
Website
geron.com
SIC Code
2834 - Pharmaceutical Preparations
Stock Symbol
GERN
NAICS Code
541714 - Research and Development in Biotechnology (except Nanobiotechnology)
Founded
1992
Employees
201-500

Section iconFunding & Financials

  • $150M

    Geron Corporation has raised a total of $150M of funding over 8 rounds. Their latest funding round was raised on Mar 19, 2024 in the amount of $150M.

  • $50M$100M

    Geron Corporation's revenue is in the range of $50M$100M

Section iconFunding & Financials

  • $150M

    Geron Corporation has raised a total of $150M of funding over 8 rounds. Their latest funding round was raised on Mar 19, 2024 in the amount of $150M.

  • $50M$100M

    Geron Corporation's revenue is in the range of $50M$100M

Ready to create more pipeline?

Get a demo and discover why thousands of SDR and Sales teams trust
LeadIQ to help them build pipeline confidently.

© LeadIQ, Inc. All rights reserved.